Loading clinical trials...

Explore the Optimal Surgical Timing for Lung Surgery and Mediastinal Surgery After COVID-19 Infection | Clinical Trials | Clareo Health

COMPLETED

Explore the Optimal Surgical Timing for Lung Surgery and Mediastinal Surgery After COVID-19 Infection

A Prospective Observational Study to Explore the Optimal Surgical Timing for Lung Surgery and Mediastinal Surgery After COVID-19 Infection

NCT05827328•Shanghai Pulmonary Hospital, Shanghai, China

View on ClinicalTrials.gov

Summary

Exploring the optimal interval time in patients with the clinical diagnosis of lung cancer or mediastinal tumors indicated for thoracic surgeries after SARS-CoV-2 infection by comparing 30-day mortality and 30-day morbidity.

Eligibility

Age

18 - 85 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•1. The patient has fully understood the nature of this study and voluntarily agreed to participate by signing an informed consent form.
•2. Participants of any gender between the ages of 18 and 85 are eligible.
•3. Preoperative imaging evaluation +/- biopsies indicates that the patient has resectable lung cancer or mediastinal tumors without distant metastasis.

Exclusion Criteria

•1. Patients who have previously undergone lung surgery;
•2. Patients previously infected with SARS-CoV-2 more than 6 months before thoracic surgery;
•3. Patients who did not receive Chest computed tomography (CT) at admission or within 7 days before surgery, or whose Chest CT at admission suggests pneumonia or current infection with SARS-CoV-2 (confirmed by routine laboratory tests as positive nucleic acid in admission or on the day of surgery);
•4. The elapsed time from SARS-CoV-2 diagnosis to surgery is within 4 weeks;
•5. Local unresectable lesions or distant metastases are found intraoperatively.

Locations (6)

Shanghai Pulmonary Hospital

Shanghai, China

Anhui Chest Hospital

Shanghai, China

Anqing Municipal Hospital

Shanghai, China

Ruijin Hospital, Shanghai Jiao Tong University School of Medicine

Shanghai, China

The First Affiliated Hospital of Anhui Medical University

Shanghai, China

Wuhan University Renmin Hospital

Shanghai, China

Key Dates

Start Date

January 29, 2023

Primary Completion Date

June 30, 2023

Completion Date

June 30, 2023

Last Updated

July 18, 2023

Enrollment

2,000

ACTUAL participants

Conditions

Thoracic DiseasesThoracic Surgery

Interventions

Observation

OTHER

Ultrasound vs. Auscultation and Fiberoptic Bronchoscopy for Double-Lumen Tube Placement

NCT07465510

Thoracic Surgery With One-lung Ventilation

View study

RECRUITINGPHASE4

Erector Spinae Block for Thoracic Surgery

NCT05521789

Pulmonary NeoplasmPulmonary Cancer+3 more

View study

RECRUITING

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 18, 2023Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Explore the Optimal Surgical Timing for Lung Surgery and Mediastinal Surgery After COVID-19 Infection

Inclusion Criteria

Exclusion Criteria

Ultrasound vs. Auscultation and Fiberoptic Bronchoscopy for Double-Lumen Tube Placement

Erector Spinae Block for Thoracic Surgery

Comparison of FCV and VCV in One-Lung Ventilation

High Dose Dexamethasone to Reduce Postoperative Pain After Video-Assisted Thoracoscopic Surgery Lobectomy /Segmentectomy

Effect of VExUS Ultrasound Protocol (Venous Excess Ultrasound) on Perioperative Fluid Management, on the Incidence of Postoperative Pulmonary Complications and Postoperative Acute Kidney Injury in Patients Undergoing Thoracic Surgery

Safety and Feasibility of a Self-Balancing Exoskeleton for Rehabilitation in the Thoracic Surgical Intensive Care Unit: a Pilot Trial